Mark Helfand

23.8k total citations · 6 hit papers
103 papers, 15.2k citations indexed

About

Mark Helfand is a scholar working on Economics and Econometrics, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mark Helfand has authored 103 papers receiving a total of 15.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Economics and Econometrics, 26 papers in General Health Professions and 25 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mark Helfand's work include Health Systems, Economic Evaluations, Quality of Life (28 papers), Meta-analysis and systematic reviews (18 papers) and Clinical practice guidelines implementation (12 papers). Mark Helfand is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (28 papers), Meta-analysis and systematic reviews (18 papers) and Clinical practice guidelines implementation (12 papers). Mark Helfand collaborates with scholars based in United States, Canada and United Kingdom. Mark Helfand's co-authors include Holger J. Schünemann, Andrew D Oxman, Jan Brożek, Gunn Elisabeth Vist, Regina Kunz, Susan L. Norris, Yngve Falck–Ytter, Joerg J Meerpohl, Howard Balshem and Kathleen N Lohr and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Mark Helfand

101 papers receiving 14.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

GRADE guidelines: 3. Rating the quality of evidence

2011 5.8k citations Howard Balshem, Mark Helfand et al. Journal of Clinical Epidemiology profile →
GRADE guidelines: 7. Rating the quality of evidence—inconsistency

2011 1.7k citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
Current methods of the U.S. Preventive Services Task Force

2001 1.5k citations Russell Harris, Mark Helfand et al. American Journal of Preventive Medicine profile →
GRADE guidelines: 8. Rating the quality of evidence—indirectness

2011 1.4k citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
GRADE guidelines: 12. Preparing Summary of Findings tables—binary outcomes

2012 555 citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
AHRQ Series Paper 5: Grading the strength of a body of evidence when comparing medical interventions—Agency for Healthcare Research and Quality and the Effective Health-Care Program

2009 417 citations Douglas K Owens, Kathleen N Lohr et al. Journal of Clinical Epidemiology profile →

Peers

Countries citing papers authored by Mark Helfand

Since Specialization

Citations

This map shows the geographic impact of Mark Helfand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Helfand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Helfand more than expected).

Fields of papers citing papers by Mark Helfand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Helfand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Helfand. The network helps show where Mark Helfand may publish in the future.

Co-authorship network of co-authors of Mark Helfand

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Helfand. A scholar is included among the top collaborators of Mark Helfand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Helfand. Mark Helfand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CARE guidelines for case reports: explanation and elaboration document. Translation into Russian 2022 ·SHILAP Revista de lepidopterología ·Melissa S. Barber, Jeffrey K Aronson, Tido von Schoen-Angerer, D. Riley, Peter Tugwell, Helmut Kiene, Mark Helfand, Douglas G. Altman, H C Sox, Paul G. Werthmann, David Moher, Richard A. Rison, Larissa Shamseer, Christian A. Koch, Gordon H. Sun, Patrick Hanaway, (unknown), James R. Carpenter, Joel Gagnier	1
2	REPRINT OF: Current Methods of the U.S. Preventive Services Task Force: A Review of the Process 2020 ·American Journal of Preventive Medicine ·Russell Harris, Mark Helfand, Steven H. Woolf, Kathleen N Lohr, Cynthia D. Mulrow, Steven M. Teutsch, David C. Atkins	9
3	Effectiveness of Models Used to Deliver Multimodal Care for Chronic Musculoskeletal Pain: a Rapid Evidence Review 2018 ·Journal of General Internal Medicine ·Kim Peterson, Johanna Anderson, Donald Bourne, Katherine Mackey, Mark Helfand	34
4	US Food and Drug Administration documents can provide unpublished evidence relevant to systematic reviews 2013 ·Journal of Clinical Epidemiology ·Marian McDonagh, Kim Peterson, Howard Balshem, Mark Helfand	14
5	GRADE guidelines: 12. Preparing Summary of Findings tables—binary outcomes breakdown → 2012 ·Journal of Clinical Epidemiology ·Gordon Guyatt, Andrew D Oxman, Nancy Santesso, Mark Helfand, Gunn Elisabeth Vist, Regina Kunz, Jan Brożek, Susan L. Norris, Joerg J Meerpohl, Ben Djulbegovic, Pablo Alonso‐Coello, Piet N. Post, Jason W. Busse, Paul Glasziou, Robin Christensen, Holger J. Schünemann	555
6	GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence 2012 ·Journal of Clinical Epidemiology ·Massimo Brunetti, Ian Shemilt, (unknown), Luke Vale, Andrew D Oxman, Joanne Lord, Jane E. Sisk, Francis Ruiz, Suzanne Hill, Gordon Guyatt, Roman Jaeschke, Mark Helfand, Robin Harbour, Marina Davoli, Laura Amato, Alessandro Liberati, Holger J. Schünemann	181
7	GRADE guidelines: 7. Rating the quality of evidence—inconsistency breakdown → 2011 ·Journal of Clinical Epidemiology ·Gordon Guyatt, Andrew D Oxman, Regina Kunz, James Woodcock, Jan Brożek, Mark Helfand, Pablo Alonso‐Coello, Paul Glasziou, Roman Jaeschke, Elie A. Akl, Susan L. Norris, Gunn Elisabeth Vist, Philipp Dahm, Vijay K. Shukla, Julian P. T. Higgins, Yngve Falck–Ytter, Holger J. Schünemann	1739
8	A CTSA Agenda to Advance Methods for Comparative Effectiveness Research 2011 ·Clinical and Translational Science ·Mark Helfand, Sean Tunis, Evelyn P Whitlock, Stephen G. Pauker, Anirban Basu, Jon A. Chilingerian, Frank E. Harrell, David Meltzer, Víctor M. Montori, Donald S. Shepard, David M. Kent	23
9	GRADE guidelines: 3. Rating the quality of evidence breakdown → 2011 ·Journal of Clinical Epidemiology ·Howard Balshem, Mark Helfand, Holger J. Schünemann, Andrew D Oxman, Regina Kunz, Jan Brożek, Gunn Elisabeth Vist, Yngve Falck–Ytter, Joerg J Meerpohl, Susan L. Norris	5791
10	Comparative Effectiveness Research: Challenges for Medical Journals 2010 ·Journal of Clinical Epidemiology ·Harold C. Sox, Mark Helfand, Jeremy Grimshaw, Kay Dickersin, David Tovey, J. André Knottnerus, Peter Tugwell	11
11	Drug Class Review: Nonsteroidal Antiinflammatory Drugs (NSAIDs): Final Update 4 Report 2010 ·Europe PMC (PubMed Central) ·Kim Peterson, Marian McDonagh, Sujata Thakurta, Tracy Dana, (unknown), Roger Chou, Mark Helfand	23
12	Grading the Strength of a Body of Evidence When Comparing Medical Interventions 2009 ·Journal of Clinical Epidemiology ·Douglas K Owens, Kathleen N Lohr, David C. Atkins, Jonathan Treadwell, James Reston, Eric B Bass, Stephanie Chang, Mark Helfand	30
13	AHRQ Series Paper 2: Principles for developing guidance: AHRQ and the Effective Health-Care Program 2009 ·Journal of Clinical Epidemiology ·Mark Helfand, Howard Balshem	42
14	Hyperbaric Oxygen Therapy for Brain Injury, Cerebral Palsy, and Stroke: Summary 2003 ·Marian McDonagh, Susan Carson, Joan S. Ash, (unknown), P. Zoē Stavri, (unknown), Mark Helfand	4
15	Universal Newborn Hearing Screening 2001 ·JAMA ·(unknown), Heather McPhillips, Robert L. Davis, Tracy A. Lieu, Charles J. Homer, Mark Helfand	283
16	Current methods of the U.S. Preventive Services Task Force breakdown → 2001 ·American Journal of Preventive Medicine ·Russell Harris, Mark Helfand, Steven H. Woolf, Kathleen N Lohr, Cynthia D. Mulrow, Steven M. Teutsch, David C. Atkins	1454
17	Clinical outcomes resulting from telemedicine interventions: a systematic review 2001 ·BMC Medical Informatics and Decision Making ·William Hersh, Mark Helfand, James Wallace, Dale F. Kraemer, Patricia Patterson, Susan Shapiro, Merwyn R. Greenlick	189
18	The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services 2001 ·American Journal of Preventive Medicine ·Somnath Saha, Thomas J. Hoerger, Michael Pignone, Steven M. Teutsch, Mark Helfand, Jeanne S. Mandelblatt	71
19	Summary Report: Evidence for the Effectiveness of Rehabilitation for Persons with Traumatic Brain Injury 1999 ·Journal of Head Trauma Rehabilitation ·Randall M. Chesnut, Nancy Carney, Hugo Maynard, N. Clay Mann, Patricia Patterson, Mark Helfand	86
20	Effect of Cognitive Rehabilitation on Outcomes for Persons with Traumatic Brain Injury: A Systematic Review 1999 ·Journal of Head Trauma Rehabilitation ·Nancy Carney, Randall M. Chesnut, Hugo Maynard, N. Clay Mann, Patricia Patterson, Mark Helfand	189

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact